Grantee Research Project Results
Associated Project Details for RFA: Development and Use of Adverse Outcome Pathways that Predict Adverse Developmental Neurotoxicity (2012)| R835541 | Establishing an AOP for the Role of the Vitamin D Receptor in Developmental Neurotoxicity | Grant | July 1, 2013 through June 30, 2016 (Extended to January 31, 2018) |
| R835550 | Identification and Scientific Validation of AOPS Involving Genomic and Nongenomic Intracellular Thyroid Hormone Signaling in Neurodevelopment | Grant | October 1, 2013 through September 30, 2016 |
| R835551 | Human Neural Stem Cell Metabolomic, Cellular and Organ Level Adverse Outcome Pathway Relationships for Endocrine Active Compounds | Grant | September 1, 2013 through August 31, 2016 (Extended to August 31, 2017) |
| R835552 | Human Stem Cell-Based Platform to Predict Selective Developmental Neurotoxicity | Grant | September 1, 2013 through August 31, 2017 |
The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.